Skip to main content

The Globe and Mail

CEO at Canopy Growth, Canada’s largest marijuana stock, is selling

At Canada’s largest marijuana stock, Canopy Growth Corp., chief executive officer Bruce Linton sold about $3.7-million worth of stock over the past month.

Clarusvisus/Getty Images/iStockphoto

The Horizons Medical Marijuana Life Sciences ETF debuted Wednesday. Insider sentiment toward the medical marijuana group is generally mixed.

At Canada's largest marijuana stock, Canopy Growth Corp., chief executive officer Bruce Linton sold about $3.7-million worth of stock over the past month. In addition, from March 9 to 31, a director sold 143,650 shares, while on March 9 he bought 20,000 shares. Ultimately, interest rates may influence the group's fate. Last fall, cannabis stocks pulled back then troughed in late December as Treasury yields peaked.

Disclaimer:

Story continues below advertisement

Ted Dixon is CEO of INK Research which provides insider news and knowledge to investors. For more background on insider reporting in Canada, visit the FAQ section at www.inkresearch.com. Securities referenced in this profile may have already appeared in recent reports distributed to INK subscribers. INK staff may also hold a position in profiled securities.

Graph Footnote:

Chart reflects public-market transactions of common shares or unit trusts by company officers and directors.

Report an error
Comments

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

We’ve made some technical updates to our commenting software. If you are experiencing any issues posting comments, simply log out and log back in.

Discussion loading… ✨